Customization: | Available |
---|---|
Certification: | ISO, FDA |
Assay Method: | HPLC, UV |
Still deciding? Get samples of US$ 0/kg
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Description: Breviscapine is extracted from Erigeron breviscapus (Vant.) Hand. -Mazz. Breviscapine is a mixture of scutellarin mainly containing scutellarin with a small amount of scutellarin, which has the functions of dilating cerebral blood vessels, reducing cerebrovascular resistance, increasing cerebral blood flow, improving microcirculation, and resisting platelet aggregation. The latest research shows that breviscapine significantly inhibited the activation of NLRP3 inflammatory cells in the hippocampus of CCI rats, down-regulate the expression of Caspase 1, IL-6 and IL-1β protein, inhibit the activation of Caspase-3 protein, and inhibit neuronal apoptosis. Functions: Breviscapine has the function os expanding cerebrovascular, reducing cerebrovascular resistance, increasing cerebral blood flow, improving microcirculation, and anti-platelet aggregation. Clinically, it is used to treat the sequelaes caused by cerebral hemorrhage, hyperviscosemia, cerebral thrombosis, coronary heart disease, angina pectoris and other diseases. |
|||||||
Item | Test Standard | Testing Result | |||||
Appearance | Powder | Complies | |||||
Color | light yellow powder | Complies | |||||
Particle Size | 100% pass 80 mesh | Complies | |||||
Oder | Characteristic | Complies | |||||
Taste | Characteristic | Complies | |||||
Loss on Drying | ≤5.0% | 2.20% | |||||
Residue on Ignition | ≤0.1% | 0.05% | |||||
Residual | ≤0.1% | Complies | |||||
Residual Ethanol | ≤0.5% | Complies | |||||
Heave Mentals | ≤10ppm | Complies | |||||
Na | ≤0.1% | <0.1% | |||||
Pb | ≤3 ppm | Complies | |||||
Total Plate | <1000CFU/g | Complies | |||||
Yeast & Mold | <100 CFU /g | Complies | |||||
E. Coli | Negative | Complies | |||||
Salmonella | Negative | Complies | |||||